CTOs on the Move

Theratechnologies

www.theratech.com

 
Theratechnologies is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.theratech.com
  • 2015 Peel Street 11th Floor
    Montreal, QC CAN H3A 1T8
  • Phone: 514.336.7800

Executives

Name Title Contact Details

Similar Companies

Axis Neuromonitoring

Axis Neuromonitoring is a company that provides high quality intraoperative neurophysiological monitoring (IONM) services to patients, surgeons, and hospitals quality control managers.

OneWorld

OneWorld provides quality affordable health care, and individuals are welcome with or without insurance, including Medicaid and Medicare. OneWorld operates 13 clinical locations in Omaha; including the clinics at the Historic Livestock Exchange Campus, OneWorld West, Northwest Omaha, Cass Family Medicine, OneWorld Bellevue, Crossroads to Health and Recovery at Community Alliance, two mobile dental clinics, four school-based health centers and the South Omaha Learning Community Centers. Established in 1970, OneWorld Community Health Centers, in partnership with the community, provides culturally respectful, quality health care with special attention to the underserved. OneWorld is a federally qualified health center (FQHC) and provides comprehensive primary health care, dental, mental health/ substance abuse services, and affordable medications.

Xenon Pharmateuticals

Xenon Pharmaceuticals (NASDAQ:XENE) – a biopharmaceutical company with operations in Vancouver, BC, Canada and Boston, MA, U.S.A. – is committed to delivering innovative medicines to provide a brighter future for patients suffering from neurological disorders. At Xenon, we are advancing an exciting pipeline of neurology-focused therapies, with a particular emphasis on novel treatments for both adult and pediatric patients with epilepsy. XEN496 is currently being evaluated in the Phase 3 “EPIK” clinical trial in young patients with KCNQ2-DEE, a rare and severe form of childhood epilepsy. Late-stage development plans are also underway for our XEN1101 program, building upon the compelling data from the Phase 2b “X-TOLE” study in adult patients with focal epilepsy. We are also proud of the leading-edge science coming out of our discovery labs, with many early-stage research programs underway. In addition to Xenon`s proprietary programs, we have ongoing collaborations with our valued pharmaceutical partners. With a healthy balance sheet to support our growth plans, we continue to build a fully-integrated, premier neuroscience company with strong discovery, development, and commercial operations. Our employees are smart, passionate, dedicated, and driven by their incredibly important work to discover, develop, and deliver new medicines for patients in need. Building and maintaining a respectful, collaborative, inclusive, and productive culture is a priority for us. We are looking for great people who thrive in a fast-paced, dynamic work environment to join our team during this transformative time for Xenon.

Med-Trans Corporation

Med-Trans Corporation is a Lewisville, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NJMHI

NJMHI is a Trenton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.